Pfizer won't seek coronavirus vaccine authorization until after election

1 min


81
12 shares, 81 points

By Zachary Brennan

Pfizer won't seek coronavirus vaccine authorization until after election

Pfizer will not seek an emergency authorization for its coronavirus vaccine until after the election, the final blow to President Donald Trump’s repeated pledges to make a shot available before Americans cast votes amid the worst pandemic in a century.

Pfizer CEO Albert Bourla said Friday that the company may know whether its vaccine is effective by the end of October, but won’t have the safety data the FDA wants at least until the end of November. Amid rising concerns about political pressure on the agency, the FDA released guidance on emergency authorizations that requires vaccine developers to provide two months of safety data on half of the trial participants following the final dose of the vaccine.

“Let me be clear, assuming positive data, Pfizer will apply for Emergency Authorization Use in the U.S. soon after the safety milestone is achieved in the third week of November,” Bourla wrote in an open letter.


Like it? Share with your friends!

81
12 shares, 81 points

What's Your Reaction?

hate hate
10
hate
confused confused
2
confused
fail fail
16
fail
fun fun
14
fun
geeky geeky
12
geeky
love love
6
love
lol lol
8
lol
omg omg
2
omg
win win
16
win

Read exclusive latest news on entertainment, music, gaming and more topics with unprecedented coverage from around the UK and US.

0 Comments

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.